Log in
Enquire now
‌

US Patent 11701396 Treatment of

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Vedanta Biosciences
Vedanta Biosciences
0
Current Assignee
Vedanta Biosciences
Vedanta Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
117013960
Date of Patent
July 18, 2023
0
Patent Application Number
167026590
Date Filed
December 4, 2019
0
Patent Citations
‌
US Patent 10064904 Treatment of
0
‌
US Patent 10350250 Treatment of clostridium difficile infection
0
‌
US Patent 10555980 Treatment of
0
‌
US Patent 10456431 Treatment of clostridium difficile infection
0
‌
US Patent 8460648 Probiotic recolonisation therapy
0
‌
US Patent 9386793 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
0
‌
US Patent 9642881 Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
0
‌
US Patent 9649345 Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
0
...
Patent Primary Examiner
‌
Mary Maille Lyons
0

Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11701396 Treatment of

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.